Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Brown

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMJ Open|June 29, 2018
Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviewsMarina T van Leeuwen, Steven Luu, Howard Gurney, et al.
Journal of Pharmacological and Toxicological Methods|September 14, 2016
Assessment of extracellular field potential and Ca<sup>2+</sup> transient signals for early QT/pro-arrhythmia detection using human induced pluripotent stem cell-derived cardiomyocytesNajah Abi-Gerges, Amy Pointon, Karen L Oldman, et al.
JNCI Cancer Spectrum|January 4, 2021
Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic ReviewsMarina T Van Leeuwen, Steven Luu, Howard Gurney, et al.
Thrombosis Research|June 27, 2014
A new structural biomarker that quantifies and predicts changes in clot strength and quality in a model of progressive haemodilutionMatthew J Lawrence, Sendhil Kumar, Karl Hawkins, et al.
ACS Chemical Biology|January 21, 2017
Phenotypic Screen for Cardiac Regeneration Identifies Molecules with Differential Activity in Human Epicardium-Derived Cells versus Cardiac FibroblastsAmalia I Paunovic, Lauren Drowley, Anneli Nordqvist, et al.
Atherosclerosis|April 19, 2015
Fractal dimension: a novel clot microstructure biomarker use in ST elevation myocardial infarction patientsMatthew J Lawrence, Ahmed Sabra, Phillip Thomas, et al.
British Journal of Haematology|October 11, 2014
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolismMatthew J Lawrence, Ahmed Sabra, Gavin Mills, et al.
Journal of Medicinal Chemistry|September 3, 2021
Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> EfficacyWilliam McCoull, Scott Boyd, Martin R Brown, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMJ Open|June 29, 2018
Cardiovascular toxicity of targeted therapies for cancer: a protocol for an overview of systematic reviewsMarina T van Leeuwen, Steven Luu, Howard Gurney, et al.
Journal of Pharmacological and Toxicological Methods|September 14, 2016
Assessment of extracellular field potential and Ca<sup>2+</sup> transient signals for early QT/pro-arrhythmia detection using human induced pluripotent stem cell-derived cardiomyocytesNajah Abi-Gerges, Amy Pointon, Karen L Oldman, et al.
JNCI Cancer Spectrum|January 4, 2021
Cardiovascular Toxicity of Targeted Therapies for Cancer: An Overview of Systematic ReviewsMarina T Van Leeuwen, Steven Luu, Howard Gurney, et al.
Thrombosis Research|June 27, 2014
A new structural biomarker that quantifies and predicts changes in clot strength and quality in a model of progressive haemodilutionMatthew J Lawrence, Sendhil Kumar, Karl Hawkins, et al.
ACS Chemical Biology|January 21, 2017
Phenotypic Screen for Cardiac Regeneration Identifies Molecules with Differential Activity in Human Epicardium-Derived Cells versus Cardiac FibroblastsAmalia I Paunovic, Lauren Drowley, Anneli Nordqvist, et al.
Atherosclerosis|April 19, 2015
Fractal dimension: a novel clot microstructure biomarker use in ST elevation myocardial infarction patientsMatthew J Lawrence, Ahmed Sabra, Phillip Thomas, et al.
British Journal of Haematology|October 11, 2014
A new biomarker quantifies differences in clot microstructure in patients with venous thromboembolismMatthew J Lawrence, Ahmed Sabra, Gavin Mills, et al.
Journal of Medicinal Chemistry|September 3, 2021
Optimization of an Imidazo[1,2-<i>a</i>]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with <i>In Vivo</i> EfficacyWilliam McCoull, Scott Boyd, Martin R Brown, et al.
Pageof 2